Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2023-09-25 Earnings Release
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces "résultats semestriels 2023" (2023 half-year results) along with strategic updates. It contains key financial highlights (revenue, net loss, cash position) and forward-looking guidance for the second half of 2023. The text also mentions that the "rapport financier semestriel 2023 a été publié ce jour" (the 2023 half-year financial report was published today) and is available on the company website. Since this document is a press release summarizing the results and announcing the availability of the full report, it fits the definition of an Earnings Release (ER) which provides initial announcements of periodical financial results (key highlights only). It is not the comprehensive report itself (which would be an IR), nor is it merely an announcement of the report's publication (RPA), as it contains substantial financial data and management commentary. Key indicators supporting ER: 1. Title: "résultats semestriels 2023". 2. Content: Summary of H1 2023 performance (revenue, loss) and outlook for H2 2023. 3. Date: September 25, 2023 (typical timing for H1 results announcement). H1 2023
2023-09-25 French
Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
Interim / Quarterly Report Classification · 1% confidence The document is explicitly titled '2023 INTERIM FINANCIAL REPORT' and covers the 'SIX MONTHS ENDED JUNE 30, 2023'. It contains comprehensive financial statements, including a balance sheet, income statement, cash flow statement, and detailed notes to the financial statements. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report (IR). H1 2023
2023-09-25 English
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces the company's participation schedule for various scientific and investor conferences during the second half of 2023. This type of announcement, detailing future events and interactions with the investment community, is characteristic of investor relations communications. It is not a full financial report (10-K, IR), an earnings release (ER), or a transcript (CT). Since it is an announcement related to investor engagement and future corporate activities, it best fits the general category of Investor Presentation (IP) if it were a presentation deck, or more broadly, a communication aimed at investors. However, given the options, this document is primarily an announcement about future events, which often accompanies or precedes investor presentations or earnings calls. Since it is a press release detailing participation in investor forums, it is most closely related to Investor Presentation (IP) or a general Regulatory Filing (RNS). Because it is a specific announcement about investor engagement rather than a general regulatory disclosure, and it is not a formal report, it aligns best with the spirit of Investor Presentation (IP) materials, even though it is a schedule announcement. Given the options, and recognizing that it is an announcement intended for investors about future engagements, 'IP' (Investor Presentation) is a plausible fit, although 'RNS' (Regulatory Filings) is also possible for a press release. Since it specifically lists investor seminars, I will lean towards 'IP' as the intended audience focus, but acknowledge it's an announcement about future events. Re-evaluating the definitions: None perfectly capture a 'Schedule of Upcoming Investor/Scientific Engagements' press release. It is not a presentation itself (IP). It is not an earnings release (ER). It is a corporate announcement. 'RNS' (Regulatory Filings) is the best fallback for corporate announcements that don't fit the specific financial report types. However, since it is explicitly about investor meetings, and often these schedules are released alongside investor materials, I will check if there is a better fit. 'RPA' is for announcing the publication of *other* reports. Given the content focuses on future investor interactions, and it's a press release, 'RNS' is the safest classification for a non-standard announcement.
2023-09-19 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces the company's participation schedule in various scientific and investor conferences during the second half of 2023. This type of announcement, detailing future events where management will present or meet investors, is best classified as an Investor Presentation (IP) related activity announcement, or more generally, a communication aimed at investors and the market about corporate visibility. Since there is no specific category for 'Conference Schedule Announcement', and the content is a formal press release detailing future investor engagement, it is closest to an Investor Presentation (IP) or a general Regulatory Filing (RNS). Given that it is a formal announcement detailing future investor engagement and scientific updates, and not a report itself, it fits well under the scope of investor relations communication. However, since it is a formal announcement of future activities rather than the presentation material itself, and it is not a standard regulatory form like 10-K or ER, the most appropriate general category for non-standard, market-facing announcements is often RNS. Upon reviewing the definitions, 'Investor Presentation (IP)' is for the presentation material itself. This document is an announcement *about* participation in investor events. If the document were announcing the *release* of a report, RPA would be used. Since this is a general market communication about corporate activities (investor meetings/scientific presence), and it is not a core financial report, RNS (Regulatory Filings - general fallback) is a strong candidate. However, because the core purpose is informing investors about where management will be presenting/meeting, it is highly related to investor relations activities. Given the options, and recognizing this is a standard press release format announcing corporate events, RNS is the safest fallback, but let's check if it fits IP better. IP is for the presentation itself. This is an announcement of participation. Therefore, RNS is the most suitable general classification for this type of corporate news release that doesn't fit a specific financial report type.
2023-09-19 English
Inside Information / Other news releases
Earnings Release Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces that CARMAT will hold a video conference on September 25, 2023, to present its "2023 half-year results and provide an update on its strategic roadmap." This is a classic announcement preceding the release of detailed financial results (which would likely be an IR or MDA). Since the document itself is an announcement about an upcoming event where results will be discussed, and it is not the full report, it fits best as an Earnings Release (ER) which typically precedes or accompanies the detailed results presentation, or potentially a Report Publication Announcement (RPA) if it were only announcing the release date. However, because it is specifically tied to the presentation of 'half-year results' via a conference call, it functions as the initial communication of the earnings period, making ER the most appropriate fit among the primary financial categories. It is not the full report (10-K or IR), nor is it a transcript (CT) or a management discussion (MDA) of the results yet. H2 2023
2023-09-11 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and announces a conference call scheduled for September 25, 2023, to present the 'résultats semestriels 2023' (2023 half-year results) and provide a strategic roadmap update. This announcement is not the full financial report itself (which would be an IR or 10-K), nor is it a transcript of the call. It is an announcement *about* an upcoming event where results will be discussed. Since the core purpose is to announce the timing and details of a presentation regarding interim financial results, it aligns best with an Earnings Release (ER) if it contained the results, or a Report Publication Announcement (RPA) if it were announcing the publication of a document. Given that it is specifically announcing a conference call to *present* the results, it functions as an advance notice related to earnings. However, the definition for Earnings Release (ER) is 'Initial announcement of quarterly/periodical financial results (key highlights only)'. Since this is an announcement of a *call* to discuss the results, and not the results themselves, it is a strong candidate for a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the document explicitly details the date/time of a presentation concerning interim results, it is most closely related to the earnings cycle. If the document contained the actual half-year results, it would be an Interim Report (IR). As it is an announcement *about* the presentation of those results, and it is a press release format, it fits the pattern of an Earnings Release (ER) announcing the event where highlights will be shared, or RPA if it were announcing the *release* of a document. Given the context of financial reporting, announcing the date of the earnings call where results are presented is often categorized under ER or RPA. Since the document is relatively long (6600 chars) and detailed, it is more than a simple RPA placeholder. It is an announcement detailing the event where the interim results will be discussed. This strongly suggests it is related to the Earnings Release cycle, even if it's the call announcement rather than the press release containing the numbers. If the document contained the actual half-year results, it would be IR. Since it announces the *presentation* of the half-year results, ER is the most appropriate fit among the specific financial reporting codes, as it precedes or accompanies the release of the key figures.
2023-09-11 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.